CL2015003104A1 - Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales - Google Patents

Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales

Info

Publication number
CL2015003104A1
CL2015003104A1 CL2015003104A CL2015003104A CL2015003104A1 CL 2015003104 A1 CL2015003104 A1 CL 2015003104A1 CL 2015003104 A CL2015003104 A CL 2015003104A CL 2015003104 A CL2015003104 A CL 2015003104A CL 2015003104 A1 CL2015003104 A1 CL 2015003104A1
Authority
CL
Chile
Prior art keywords
vaccination
fish
vaccines
encapsulating
animals
Prior art date
Application number
CL2015003104A
Other languages
English (en)
Inventor
Moti Harel
Brian Carpenter
Original Assignee
Advance Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46514232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015003104(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/466,279 external-priority patent/US8778384B2/en
Application filed by Advance Bionutrition Corp filed Critical Advance Bionutrition Corp
Publication of CL2015003104A1 publication Critical patent/CL2015003104A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIÓN DE AGENTE INMUNOGÉNICO ENCAPSULADO PARA ENTREGA ORAL; MÉTODO DE PREPARACIÓN; Y USO PARA PREVENIR ANEMIA INFECCIOSA DEL SALMON (ISA) Y SEPTICEMIA RICKETTSIAL SALMONIDEA (SRS) EN PECES (DIVISIONAL DE SOL. N° 1995-12).
CL2015003104A 2012-05-08 2015-10-21 Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales CL2015003104A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/466,279 US8778384B2 (en) 2008-03-24 2012-05-08 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Publications (1)

Publication Number Publication Date
CL2015003104A1 true CL2015003104A1 (es) 2016-06-24

Family

ID=46514232

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2012001995A CL2012001995A1 (es) 2012-05-08 2012-07-18 Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno
CL2015003104A CL2015003104A1 (es) 2012-05-08 2015-10-21 Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2012001995A CL2012001995A1 (es) 2012-05-08 2012-07-18 Composicion oral de un agente inmunogénico; metodo para preparar dicha compposicion; metodo de vacunación o de reforzamiento por via oral de un animal contra un patógeno

Country Status (5)

Country Link
EP (1) EP2662074B1 (es)
CA (1) CA2783146C (es)
CL (2) CL2012001995A1 (es)
DK (1) DK2662074T3 (es)
ES (1) ES2693539T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2015002907A1 (es) * 2015-09-29 2016-06-17 Univ Santiago Chile Vacuna oral contra isav que comprende nanopartículas de quitosán que encapsulan una virina del virus isa y nanoparticulas de quitosán que encapsulan un adyuvante que consiste en un adn que se codifica para la replicasa/transcriptasa de un alfavirus de salmón (replicón), proceso de preparación, método para tratar peces infectados con isav y método para estimular la respuesta inmune en peces.
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
PT3589331T (pt) 2017-02-28 2021-07-22 Lument Ab Agente de contraste peroral negativo para tc abdominal
CN109172817B (zh) * 2018-08-16 2021-10-26 华中农业大学 猪流行性腹泻病毒减毒活疫苗壳聚糖微球的制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2105129B1 (en) * 2008-03-24 2018-01-17 Intervet International B.V. Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals
WO2010111565A2 (en) * 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

Also Published As

Publication number Publication date
EP2662074B1 (en) 2018-09-26
EP2662074A1 (en) 2013-11-13
CA2783146C (en) 2020-04-07
DK2662074T3 (en) 2018-12-10
CA2783146A1 (en) 2013-11-08
ES2693539T3 (es) 2018-12-12
CL2012001995A1 (es) 2012-12-14

Similar Documents

Publication Publication Date Title
CL2019003264A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas. (divisional solicitud 201703151)
BRPI1013780B8 (pt) Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
MX363529B (es) Vesículas de membrana externa.
BR112015018877A2 (pt) Método para preparar uma composição farmacêutica, e, composição farmacêutica imunogênica
AR098882A1 (es) Composición dentífrica que comprende óxido de zinc y citrato de zinc
CO6331297A2 (es) Composiciones adyuvantes novedosas
EA201590491A1 (ru) Иммуногенная композиция
CL2015003104A1 (es) Composiciones y métodos para encapsular vacunas para vacunación oral y vacunación de refuerzo en peces y otros animales
MX2022006512A (es) Lipidos cationicos de trialquilo y metodos de uso de los mismos.
MX377244B (es) Formulacion arn para inmunoterapia.
EA202090699A2 (ru) Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения
MX346094B (es) Método de administración de vacunas.
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
CL2015001111A1 (es) Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna.
MX2021006021A (es) Procedimiento de disminucion de la inmunogenicidad de proteinas y peptidos.
MX2020011712A (es) Vacunas de nanoparticulas multivalentes contra la influenza.
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
MX391930B (es) Vacuna contra la fiebre aftosa.
BR112013019924A8 (pt) Composições para cuidado oral
ZA201602148B (en) Immunogenic formulation containing recombinant live bcg that express antigens of metapneumovirus (hmpv), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
CL2012003219A1 (es) Parapoxvirus recombinante que comprende un parapoxvirus y adn heterólogo derivado de un virus de la rabia; procedimiento de preparación de dicho parapoxvirus; composicion inmunogénica; uso de la composicion para inducir respuesta inmunitaria contra el virus de la rabia en un animal.
MX2014008853A (es) Inulina y formulaciones de acetato de inulina.
PH12015501251A1 (en) Compositions and methods for treating dental caries